Literature DB >> 13560343

A controlled study of chloroquine as an antirheumatic agent.

A S COHEN, E CALKINS.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; CHLOROQUINE/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13560343     DOI： 10.1002/art.1780010403

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

1.  Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year.

Authors:  A FREEDMAN; V L STEINBERG
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

2.  Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.

Authors:  A J POPERT; K A MEIJERS; J SHARP; F BIER
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

3.  A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.

Authors:  I H Nuver-Zwart; P L van Riel; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

Review 4.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 5.  Rational use of disease-modifying antirheumatic drugs.

Authors:  D E Furst
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

6.  Chloroquine in long-term treatment of rheumatoid arthritis.

Authors:  A Bjelle; A Björnham; A Larsen; T Mjörndal
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

7.  Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness.

Authors:  R B Landewé; A M Miltenburg; M J Verdonk; C L Verweij; F C Breedveld; M R Daha; B A Dijkmans
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.